Skip to main content
Premium Trial:

Request an Annual Quote

Cardio Diagnostics PrecisionCHD

Cardio Diagnostics has launched its PrecisionCHD test for detecting coronary heart disease. The test uses epigenetic and genetic biomarkers, as well as a proprietary machine-learning model, to detect heart disease in men and women. It also has an accompanying Actionable Clinical Intelligence, which maps a patient's biomarker profile onto modifiable risk factors like diabetes, hypertension, and smoking. The test can be administered in provider settings or at home with self-sampling and telehealth visits. The technology will be available exclusively for existing customers, with a nationwide rollout to follow.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.